Most Read Articles
Jairia Dela Cruz, 16 Sep 2020
In patients with heart failure with reduced ejection fraction (HFrEF) receiving angiotensin-converting-enzyme (ACE) inhibitors, high dosing confers benefits for the risk of death or hospitalization that are similar to that obtained with lower dosing, according to a systematic review and meta-analysis.
Pearl Toh, 09 Mar 2020
A combination therapy of enfortumab vedotin and pembrolizumab shows promising activity, with rapid and durable responses in the first-line setting for patients with metastatic urothelial carcinoma (mUC) ineligible to receive cisplatin, according to updates from the EV-103* study presented at GUCS 2020.
Pearl Toh, 2 days ago
Early and sustained treatments with simplified regimen are the key to achieving good asthma control, said experts during a presentation at the ERS 2020 Congress.
Yesterday
Severely ill patients with COVID-19 have low levels of several nutrients, with vitamin D and selenium being the most prevalent, a study has found. This suggests the possibility that nutritional deficiencies may increase susceptibility to the disease.

นวัตกรรมโปรตีนเบต้าเคซีนต่อผลกระทบเชิงสุขภาพ

Dr. Panicha Tangtrongchitr
MD
16 Sep 2020
น้ำนมและผลิตภัณฑ์จากนม เป็นแหล่งคุณค่าทางโภชนาการที่สำคัญของร่างกาย อย่างไรก็ตามผู้บริโภคจำนวนไม่น้อยที่ไม่สามารถดื่มนมได้ เนื่องจากมีอาการแพ้ หรือมีภาวะไม่ทนต่อแลคโตส ซึ่งเป็นภาวะที่พบมากในกลุ่มคนเอเชีย สาเหตุเกิดจากการขาดเอนไซม์แลคเตสที่มีหน้าที่ในการย่อยน้ำตาลแลคโตสที่พบในนมวัว ผลก็คือ ผู้ที่มีภาวะพร่องเอนไซม์แลคเตสจะมีอาการท้องอืด ปวดแน่นท้อง มีลมในท้อง และรู้สึกอาหารไม่ย่อย
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Thailand digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Jairia Dela Cruz, 16 Sep 2020
In patients with heart failure with reduced ejection fraction (HFrEF) receiving angiotensin-converting-enzyme (ACE) inhibitors, high dosing confers benefits for the risk of death or hospitalization that are similar to that obtained with lower dosing, according to a systematic review and meta-analysis.
Pearl Toh, 09 Mar 2020
A combination therapy of enfortumab vedotin and pembrolizumab shows promising activity, with rapid and durable responses in the first-line setting for patients with metastatic urothelial carcinoma (mUC) ineligible to receive cisplatin, according to updates from the EV-103* study presented at GUCS 2020.
Pearl Toh, 2 days ago
Early and sustained treatments with simplified regimen are the key to achieving good asthma control, said experts during a presentation at the ERS 2020 Congress.
Yesterday
Severely ill patients with COVID-19 have low levels of several nutrients, with vitamin D and selenium being the most prevalent, a study has found. This suggests the possibility that nutritional deficiencies may increase susceptibility to the disease.